Detailed answers about ODURO PHARMACEUTICALS LTD, including incorporation, status, business activity, and accounts information.
When was ODURO PHARMACEUTICALS LTD founded?
ODURO PHARMACEUTICALS LTD was officially incorporated on 18 March 2019 and is registered under company number 11887290. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ODURO PHARMACEUTICALS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ODURO PHARMACEUTICALS LTD?
ODURO PHARMACEUTICALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ODURO PHARMACEUTICALS LTD do?
ODURO PHARMACEUTICALS LTD operates in the following sectors: 01280 - Growing of spices, aromatic, drug and pharmaceutical crops, 21100 - Manufacture of basic pharmaceutical products, 46460 - Wholesale of pharmaceutical goods, 71122 - Engineering related scientific and technical consulting activities. These SIC codes provide insight into the company's business activities and industry focus.
What is ODURO PHARMACEUTICALS LTD's registered address?
The registered office address of ODURO PHARMACEUTICALS LTD is 82A JAMES CARTER ROAD, MILDENHALL, BURY ST. EDMUNDS, SUFFOLK, UNITED KINGDOM, IP28 7DE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ODURO PHARMACEUTICALS LTD financially stable?
The most recent accounts for ODURO PHARMACEUTICALS LTD were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.